During the past decade, Hospital de Cabueñes conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 6 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 2 clinical trials were completed. i.e. 8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Cabueñes" #1 sponsor was "PETHEMA Foundation" with 9 trials, followed by "Fundación EPIC" with 6 trials sponsored, "Celgene" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Fundación de Investigación Biomédica - Hospital Universitario de La Princesa" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Cabueñes" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Celgene" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Adknoma" with 1 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Cabueñes" are "Multiple Myeloma" (12 trials), "Coronary Artery Disease" (7 trials), "Breast Cancer" (2 trials), "Coronary Disease" (2 trials) and "Follicular Lymphoma" (2 trials). Many other conditions were trialed in "Hospital de Cabueñes" in a lesser frequency.

Most popular intervention types in "Hospital de Cabueñes" are "Drug" (36 trials), "Other" (9 trials), "Procedure" (4 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (8 trials), "Lenalidomide" (6 trials), "Bortezomib" (5 trials), "Daratumumab" (4 trials) and "Carfilzomib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Cabueñes" are 56 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Cabueñes". 2 are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital de Cabueñes, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Cabueñes, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 5 trials that are defined as “Not Applicable".